Jay Jeffrey R 13F Holdings · last filed Q2 2013
Jay Jeffrey R reported 27 securities worth $126.55M in its SEC 13F filing for Q2 2013 (period ended 2013-06-30). Top holdings: HPTX (16.76%), FURX (13.30%), STML (11.22%). Among its top 25 positions this quarter: 25 new.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | HPTX | HYPERION THERAPEUTICS INC. | $21.2M | 16.76% | 963,961 | New |
| 2 | FURX | FURIEX PHARMACEUTICAL, INC. | $16.8M | 13.30% | 494,100 | New |
| 3 | STML | STEMLINE THERAPEUTICS INC. | $14.2M | 11.22% | 595,493 | New |
| 4 | ALBO | BIODEL INC. | $7.7M | 6.12% | 1.9M | New |
| 5 | AMBIT BIOSCIENCES CORP | $7.0M | 5.53% | 1.0M | New | |
| 6 | GERN | GERON CORPORATION | $5.6M | 4.45% | 3.8M | New |
| 7 | SAVA | PAIN THERAPEUTICS INC. | $5.1M | 4.06% | 2.3M | New |
| 8 | NUWE | SUNSHINE HEART INC. | $5.1M | 4.03% | 950,000 | New |
| 9 | DRTX | DURATA THERAPEUTICS INC. | $4.6M | 3.64% | 639,433 | New |
| 10 | NORDION INC. | $4.0M | 3.14% | 537,500 | New | |
| 11 | HZNP | HORIZON PHARMA, INC. | $3.9M | 3.10% | 1.6M | New |
| 12 | ACHV | ONCOGENEX PHARMACEUTICAL INC. | $3.4M | 2.69% | 347,004 | New |
| 13 | IPXL | IMPAX LABORATORIES, INC. | $3.0M | 2.36% | 150,000 | New |
| 14 | TRIB | TRINITY BIOTECH PLC | $2.7M | 2.17% | 163,140 | New |
| 15 | SRGA | RTI BIOLOGICS, INC. | $2.5M | 2.00% | 673,898 | New |
| 16 | DYAX | DYAX CORP | $2.5M | 1.99% | 728,063 | New |
| 17 | MSTX | MAST THERAPEUTICS INC. | $2.5M | 1.97% | 5.8M | New |
| 18 | PLX | PROTALIX BIOTHERAPEUTICS INC. | $2.0M | 1.55% | 399,007 | New |
| 19 | MYGN | MYRIAD GENETICS INC. | $1.9M | 1.49% | 70,000 | New |
| 20 | VOLC | VOLCANO CORPORATION | $1.8M | 1.43% | 100,000 | New |
| 21 | CBIO | TARGACEPT, INC. | $1.6M | 1.24% | 367,709 | New |
| 22 | AVNR | AVANIR PHARMACEUTICALS INC. | $1.2M | 0.94% | 258,600 | New |
| 23 | XNPT | XENOPORT INC. | $1.2M | 0.91% | 232,977 | New |
| 24 | MEIP | MEI PHARMA INC. | $1.1M | 0.89% | 157,661 | New |
| 25 | PTXTQ | PERNIX THERAPEUTICS HOLDINGS | $1.1M | 0.85% | 297,187 | New |
Source: SEC Form 13F filings · as of 2013-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR